Scientific Advisors

13/08/2010

The following distinguished scientists are among those who have kindly agreed to be scientific advisors to the Beckley Foundation.

DR. ALBERT HOFMANN, the discoverer of LSD, was the founding member of the Beckley Foundation’s Scientific Advisory Board until his death in April 2008 at the age of 102.

 

 

 

http://www.beckleyfoundation.org/wordpress/wp-content/uploads/2010/08/shulgin_alexander_article1_sasha1_med.gif

 ALEXANDER ‘SASHA’ SHULGIN, PhD. Pharmacologist, chemist and psychoactive drug researcher. Author of PiHKAL, TiHKAL and The Shulgin Index. Sasha was a very dear friend of Amanda’s, and was an early member of the Scientific Advisory Board. He died in June 2014 at the age of 88.

 

 

 

DR. RONALD SANDISON, B.Sc., M.B., B.S., F.R.C. Psych, A.K.C. Consultant Psychiatrist, Psychotherapist and Group Analyst. Consultant psychiatrist at Powick Hospital Worcester, 1952-1964, pioneering the use of LSD and psychedelic drugs as an adjunct to psychotherapy. Died age 94 in June 2010.

 

 

 

 


Scientific Advisors

 SIR (PROF.) COLIN BLAKEMORE, FMedSci, Hon FRCP, FRS  

Former Chief Executive of the British Medical Research Council (MRC). Professor of Neuroscience and Philosophy at the School of Advanced Study, University of London, and Emeritus Professor of Neuroscience at the University of Oxford. Director of the Oxford Centre for Cognitive Neuroscience. Author of many books including The Mind Machine, Mechanics of the Mind and Vision: Coding and Efficiency.


PROF. GUSTAV BORN MA, DPhil, FRCP, FRS, FKC

Emeritus Professor of Pharmacology at King’s College London and Professor at the William Harvey Research Institute, St. Bartholomew’s Hospital Medical College.


PROF GORDON CLARIDGE, MA, DSc, PhD 

Emeritus Professor of Abnormal Psychology in Oxford University and Emeritus Fellow of Magdalen College. Fellow of the British Psychological Society, and Author of The Origins of Mental Illness and Schizotipy: Implications for Illness and Health.


PROF. VALERIE CURRAN, PhD

Professor of Psychopharmacology at University College London. Principal Editor of Psychopharmacology since 2003.


PROF. MARK GEYER, PhD

Distinguished Professor of Psychiatry and Neurosciences and Vice-Chair for Scientific Affairs in Psychiatry at the University of California, San Diego. Past President of the International Behavioral Neuroscience Society. Scientific Advisor to European Union’s Innovative Medicine Initiative, and 2011 awardee of Bleuler Prize for Research in the Schizophrenias.


PROF. LESTER GRINSPOON, MD

Associate Professor Emeritus of Psychiatry at Harvard Medical School. Fellow of the American Association for the Advancement of Science and the American Psychiatric Association, and was founding editor of the American Psychiatric Association Annual Review and the Harvard Mental Health Letter. Author of Marihuana Reconsidered, Psychedelic Drugs Reconsidered and Marijuana: the Forbidden Medicine.

 

 


PROF. LESLIE L. IVERSEN, PhD, FRS

Chair of the Advisory Council on the Misuse of Drugs, UK, and Visiting Professor of Pharmacology, University of Oxford. Former Director of the MRC Neurochemical Pharmacology Unit, Cambridge. Author of The Science of Marijuana.


PROF. YURI E. MOSKALENKO, PhD

Head of the Laboratory, Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences. Doctor of Sciences, Professor of Physiology, Honour Scientist of The Russian Federation, Academician of International Astronautics Academy.


PROF. DAVE E. NICHOLS, PhD

Emeritus Professor of Pharmacology, Purdue University, USA, and Adjunct Professor at the University of North Caroline Chapel Hill, NC.  Previously member of numerous NIH, NIMH and NIDA advisory groups. President, co-Founder  and Director of the Heffter Research Institute.


PROF. DAVID NUTT, MD, FRCP, FRCPsych, FMedSci

Edmond J Safra Chair in Neuropsychopharmacology at Imperial College London, and Director of the Neuropsychopharmacology Unit in the Division of Brain Sciences. Chair of the Independent Scientific Committee on Drugs (ISCD) and Vice- President of the European Brain Council. Fellow of the Royal Colleges of Physicians and of Psychiatrists and Fellow of the Academy of Medical Sciences.  Former President of the European College of Neuropsychopharmacology (ECPN), the British Neuroscience Association and British Association of Psychopharmacology. Editor of the Journal of Psychopharmacology. Author of Drugs without the Hot Air.


PROF. ROGER PERTWEE, MD, DPhil, DSc

Chair in Neuropharmacology at the University of Aberdeen, Director of Pharmacology for GW Pharmaceuticals, co-chairman of the International Union of Pharmacology (IUPHAR) Subcommittee on Cannabinoid Receptors.


PROF. VILAYANUR S. RAMACHANDRAN, MD, PhD

Director of the Centre for Brain and Cognition, Professor of the Psychology Department and Neuroscience Program, University of California, San Diego. Fellow of All Souls’ College, Oxford, and of the Institute for Advanced Studies in Behavioural Sciences at Stanford. Author of books including Phantoms in the Brain, The Tell-Tale Brain and The Emerging Mind.

 

 


PROF. TREVOR ROBBINS,

Head of Department of Psychology and Professor of Cognitive Neuroscience at the University of Cambridge. Angharad Dodds John Fellow in Mental Health and Neuropsychiatry and Professor of Cognitive Neuroscience at Downing College Cambridge.

Comments on this entry are closed.